TY - JOUR
T1 - Brief Report
T2 - Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV
AU - Kaplan, Alyson
AU - Simon, Tracey G.
AU - Henson, Jacqueline B.
AU - Wang, Thomas
AU - Zheng, Hui
AU - Osganian, Stephanie A.
AU - Rosenblatt, Russell
AU - Lake, Jordan
AU - Corey, Kathleen E.
N1 - Funding Information:
K.E.C. consults for BMS, Gilead and Novo Nordisk. She also has grant funding from Boeheringer-Ingelheim and Novartis. J.L. has served as a consultant to Gilead Sciences and Merck, and receives research support from Gilead Sciences. The remaining author have no conflicts of interest to disclose.
Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Background:Nonalcoholic fatty liver disease (NAFLD) and HIV are independently associated with cardiovascular disease (CVD). However, the factors associated with NAFLD in persons living with HIV (PWH) and whether CVD is more frequent in PWH with NAFLD are currently unknown.Methods:From the Partners HealthCare Research Patient Data Registry, we identified PWH with and without NAFLD between 2010 and 2017. NAFLD was defined using validated histological or radiographic criteria. CVD was defined by an ICD-9 diagnosis of coronary artery disease, myocardial infarction, coronary revascularization, peripheral vascular disease, heart failure, transient ischemic attack, or stroke and was confirmed by clinician review. Multivariable logistic regression was performed to examine the relationship between NAFLD and CVD.Results:Compared with PWH without NAFLD (n = 135), PWH with NAFLD (n = 97) had higher body mass index and more frequently had hypertension, obstructive sleep apnea, diabetes mellitus, dyslipidemia, coronary artery disease, and CVD (P < 0.01 for all). PWH with NAFLD were also more likely to have CD4+T-cell counts (CD4) <200 cells/mm3. In multivariable models, the presence of NAFLD was significantly associated with CVD (adjusted odds ratio 3.08, 95% confidence interval: 1.37 to 6.94) and CD4 <200 cells/mm3(adjusted odds ratio 4.49, 95% confidence interval: 1.74 to 11.55).Conclusion:In PWH, CVD was independently associated with prevalent NAFLD after controlling for traditional CVD risk factors. NAFLD was also associated with CD4 <200 cells/mm3, suggesting that immune dysfunction may be related to NAFLD. Both CVD and low CD4+count as risk factors for NAFLD require prospective evaluation.
AB - Background:Nonalcoholic fatty liver disease (NAFLD) and HIV are independently associated with cardiovascular disease (CVD). However, the factors associated with NAFLD in persons living with HIV (PWH) and whether CVD is more frequent in PWH with NAFLD are currently unknown.Methods:From the Partners HealthCare Research Patient Data Registry, we identified PWH with and without NAFLD between 2010 and 2017. NAFLD was defined using validated histological or radiographic criteria. CVD was defined by an ICD-9 diagnosis of coronary artery disease, myocardial infarction, coronary revascularization, peripheral vascular disease, heart failure, transient ischemic attack, or stroke and was confirmed by clinician review. Multivariable logistic regression was performed to examine the relationship between NAFLD and CVD.Results:Compared with PWH without NAFLD (n = 135), PWH with NAFLD (n = 97) had higher body mass index and more frequently had hypertension, obstructive sleep apnea, diabetes mellitus, dyslipidemia, coronary artery disease, and CVD (P < 0.01 for all). PWH with NAFLD were also more likely to have CD4+T-cell counts (CD4) <200 cells/mm3. In multivariable models, the presence of NAFLD was significantly associated with CVD (adjusted odds ratio 3.08, 95% confidence interval: 1.37 to 6.94) and CD4 <200 cells/mm3(adjusted odds ratio 4.49, 95% confidence interval: 1.74 to 11.55).Conclusion:In PWH, CVD was independently associated with prevalent NAFLD after controlling for traditional CVD risk factors. NAFLD was also associated with CD4 <200 cells/mm3, suggesting that immune dysfunction may be related to NAFLD. Both CVD and low CD4+count as risk factors for NAFLD require prospective evaluation.
KW - CAD
KW - CVD
KW - HIV
KW - NAFLD
KW - PWH
UR - http://www.scopus.com/inward/record.url?scp=85087320140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087320140&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000002359
DO - 10.1097/QAI.0000000000002359
M3 - Article
C2 - 32235172
AN - SCOPUS:85087320140
SN - 1525-4135
VL - 84
SP - 400
EP - 404
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 4
ER -